Streetbeat News

Earnings

OBIO

Orchestra BioMed Holdings (OBIO) reported Q4 earnings with a loss of $(0.37) per share, slightly better than the expected $(0.38). However, their sales of $262K fell significantly short of the $990K estimate, marking a substantial year-over-year decline in performance.

Portfolio Pulse from Happy Mohamed

March 28, 2024 | 3:46 am

IKT

Inhibikase Therapeutics (NASDAQ:IKT) reported a Q4 EPS of $(0.64), surpassing the $(0.85) estimate, marking a 37.25% improvement year-over-year. However, sales plummeted to $1.00K from $63.57K YoY, a 98.43% decrease.

Portfolio Pulse from Happy Mohamed

March 28, 2024 | 3:45 am

CMCT

Creative Media (NASDAQ:CMCT) reported Q4 earnings with a loss of $(0.72) per share, missing the $(0.48) estimate by 50%, and a sales figure of $29.47M, missing the $30.20M estimate by 2.42%. This represents an 84.62% increase in losses and a 13.92% increase in sales from the same period last year.

Portfolio Pulse from Happy Mohamed

March 28, 2024 | 3:45 am

AQMS

Aqua Metals (NASDAQ:AQMS) reported a Q4 EPS loss of $(0.04), surpassing the analyst consensus estimate of $(0.05) by 20%. This represents a 20% improvement over the same period last year.

Portfolio Pulse from Happy Mohamed

March 28, 2024 | 3:42 am

MTNB

Matinas BioPharma Holdings reported a Q4 EPS loss of $(0.03), a 50% increase in losses compared to $(0.02) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

March 28, 2024 | 3:42 am

BEST

BEST Inc. reported a Q4 adjusted loss per ADS from continuing operations of $1.00, with sales totaling $315.00 million.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:05 pm

CWCO

Consolidated Water Co. (CWCO) reported Q4 earnings of $0.67 per share, surpassing the $0.44 estimate, marking a 318.75% increase from last year. Sales reached $53.25M, beating the $45.25M estimate, up 87.50% from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 27, 2024 | 10:04 pm

INTT

inTest (AMEX:INTT) reported Q4 earnings with an EPS of $0.16, beating the estimate of $0.13 by 23.0%. However, revenue decreased by $4.52 million compared to the same period last year. Despite beating EPS estimates in previous quarters, such performance was followed by a 4.0% drop in share price the next day. The company's past earnings performance shows a consistent beat on EPS estimates but varying revenue figures.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 9:50 pm

INTT

inTest (AMEX:INTT) reported Q4 2023 earnings of $0.16 per share, surpassing the $0.14 estimate. However, their sales of $27.884M fell short of the $29.152M estimate, marking a 13.95% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:47 pm

VUZI

Vuzix has announced a delay in filing its 10-K annual report for 2023 due to the expanded nature of its audit, which is focusing on certain transactions and the time required to complete it.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:46 pm